1BYQ | A:11-223 | HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG |
1EA6 | A:27-231; B:27-231 | N-TERMINAL 40KDA FRAGMENT OF NHPMS2 COMPLEXED WITH ADP |
1H7S | A:29-231; B:33-231 | N-TERMINAL 40KDA FRAGMENT OF HUMAN PMS2 |
1H7U | A:31-231; B:32-231 | HPMS2-ATPGS |
1OSF | A:9-223 | HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N,N-DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN |
1UY6 | A:17-224 | HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE |
1UY7 | A:16-224 | HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(4-METHOXY-BENZYL)-9H-PURIN-6-YLAMINE |
1UY8 | A:17-224 | HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3-TRIMETHOXY-BENZYL)-9H-PURIN-6YLAMINE |
1UY9 | A:16-224 | HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-PURIN-6-YLAMINE |
1UYC | A:16-224 | HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE |
1UYD | A:16-224 | HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE |
1UYE | A:16-224 | HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE |
1UYF | A:16-224 | HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-2-FLUORO-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE |
1UYG | A:16-224 | HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE |
1UYH | A:16-224 | HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE |
1UYI | A:16-224 | HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9-PENT-9H-PURIN-6-YLAMINE |
1UYK | A:16-224 | HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-2-FLUORO-9H-PURIN-6-YLAMINE |
1UYL | A:17-224 | STRUCTURE-ACTIVITY RELATIONSHIPS IN PURINE-BASED INHIBITOR BINDING TO HSP90 ISOFORMS |
1UYM | A:16-226 | HUMAN HSP90-BETA WITH PU3 (9-BUTYL-8(3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE) |
1Y8N | A:184-368 | CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX |
1Y8O | A:184-368 | CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX |
1Y8P | A:184-368 | CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX |
1YC1 | A:15-224 | CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES |
1YC3 | A:10-223 | CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES |
1YC4 | A:15-224 | CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES |
1YER | A:17-223 | HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "CLOSED" CONFORMATION |
1YES | A:11-223 | HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "OPEN" CONFORMATION |
1YET | A:11-223 | GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN-BINDING DOMAIN |
1ZXM | A:38-276; B:38-276 | HUMAN TOPO IIA ATPASE/AMP-PNP |
1ZXN | C:37-287; A:37-276; B:37-276; D:37-287 | HUMAN DNA TOPOISOMERASE IIA ATPASE/ADP |
2BSM | A:16-224 | NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN |
2BT0 | A:16-224; B:16-224 | NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN |
2BTZ | A:179-362 | CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS |
2BU2 | A:179-362 | CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS |
2BU5 | A:179-362 | CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS |
2BU6 | A:179-362 | CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS |
2BU7 | A:179-362 | CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS |
2BU8 | A:179-362 | CRYSTAL STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 2 CONTAINING PHYSIOLOGICAL AND SYNTHETIC LIGANDS |
2BYH | A:11-225 | 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE |
2BYI | A:11-225 | 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE |
2BZ5 | A:16-225; B:16-225 | STRUCTURE-BASED DISCOVERY OF A NEW CLASS OF HSP90 INHIBITORS |
2CCS | A:16-224 | HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-3-YL)-BENZENE-1,2-DIOL |
2CCT | A:16-224 | HUMAN HSP90 WITH 5-(5-CHLORO-2,4-DIHYDROXY-PHENYL)-4-PIPERAZIN-1-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE |
2CCU | A:16-224 | HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4-METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3-YL)-BENZENE-1,3-DIOL |
2E0A | A:190-374; B:190-374 | CRYSTAL STRUCTURE OF HUMAN PYRUVATE DEHYDROGENASE KINASE 4 IN COMPLEX WITH AMPPNP |
2FWY | A:17-223 | STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATER SOLUBLE INHIBITOR PU-H64 |
2FWZ | A:16-223 | STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATER SOLUBLE INHIBITOR PU-H71 |
2H55 | A:16-224 | STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT WATER SOLUBLE INHIBITOR PU-DZ8 |
2JJC | A:17-223 | HSP90 ALPHA ATPASE DOMAIN WITH BOUND SMALL MOLECULE FRAGMENT |
2K5B | A:14-223 | HUMAN CDC37-HSP90 DOCKING MODEL BASED ON NMR |
2PNR | A:184-368; E:184-368; B:184-368; F:184-368 | CRYSTAL STRUCTURE OF THE ASYMMETRIC PDK3-L2 COMPLEX |
2Q8F | A:215-399 | STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 1 |
2Q8G | A:215-399 | STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 1 IN COMPLEX WITH GLUCOSE-LOWERING DRUG AZD7545 |
2Q8H | A:215-399 | STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 1 IN COMPLEX WITH DICHLOROACETATE (DCA) |
2Q8I | A:184-368 | PYRUVATE DEHYDROGENASE KINASE ISOFORM 3 IN COMPLEX WITH ANTITUMOR DRUG RADICICOL |
2QF6 | A:17-223; B:17-223; C:17-223; D:17-223 | HSP90 COMPLEXED WITH A56322 |
2QFO | A:17-223; B:17-223 | HSP90 COMPLEXED WITH A143571 AND A516383 |
2QG0 | A:17-223; B:17-223 | HSP90 COMPLEXED WITH A943037 |
2QG2 | A:17-223 | HSP90 COMPLEXED WITH A917985 |
2UWD | A:16-224 | INHIBITION OF THE HSP90 MOLECULAR CHAPERONE IN VITRO AND IN VIVO BY NOVEL, SYNTHETIC, POTENT RESORCINYLIC PYRAZOLE, ISOXAZOLE AMIDE ANALOGS |
2VCI | A:16-224 | 4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER |
2VCJ | A:16-224 | 4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER |
2WI1 | A:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2WI2 | A:16-224; B:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2WI3 | A:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2WI4 | A:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2WI5 | A:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2WI6 | A:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2WI7 | A:16-224 | ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE HSP90 CHAPERONE |
2XAB | A:16-224; B:16-224 | STRUCTURE OF HSP90 WITH AN INHIBITOR BOUND |
2XDK | A:11-225 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XDL | A:17-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XDS | A:17-223 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XDU | A:17-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XDX | A:11-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XHR | A:17-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XHT | A:12-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XHX | A:11-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XJG | A:11-223 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XJJ | A:17-224; B:17-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XJX | A:11-231 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2XK2 | A:12-224 | STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND |
2ZDX | A:190-374; B:190-374 | INHIBITOR-BOUND STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 4 |
2ZDY | A:190-374; B:190-374 | INHIBITOR-BOUND STRUCTURES OF HUMAN PYRUVATE DEHYDROGENASE KINASE 4 |
2ZKJ | B:190-374; A:190-374 | CRYSTAL STRUCTURE OF HUMAN PDK4-ADP COMPLEX |
3BM9 | A:17-223 | DISCOVERY OF BENZISOXAZOLES AS POTENT INHIBITORS OF CHAPERONE HSP90 |
3BMY | A:11-223 | DISCOVERY OF BENZISOXAZOLES AS POTENT INHIBITORS OF CHAPERONE HSP90 |
3FT5 | A:16-223 | STRUCTURE OF HSP90 BOUND WITH A NOVEL FRAGMENT |
3FT8 | A:16-223 | STRUCTURE OF HSP90 BOUND WITH A NOVAL FRAGMENT. |
3HEK | A:10-229; B:9-231 | HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH 1-{4-[(2R)-1-(5-CHLORO-2,4-DIHYDROXYBENZOYL)PYRROLIDIN-2-YL]BENZYL}-3,3-DIFLUOROPYRROLIDINIUM |
3HHU | A:16-223; B:16-224 | HUMAN HEAT-SHOCK PROTEIN 90 (HSP90) IN COMPLEX WITH {4-[3-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-5-THIOXO- 1,5-DIHYDRO-[1,2,4]TRIAZOL-4-YL]-BENZYL}-CARBAMIC ACID ETHYL ESTER {ZK 2819} |
3K97 | A:16-225 | HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH 4-CHLORO-6-{[(2R)-2-(2-METHYLPHENYL)PYRROLIDIN-1-YL]CARBONYL}BENZENE-1,3-DIOL |
3K98 | A:9-227; B:9-229 | HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH (1R)-2-(5-CHLORO-2, 4-DIHYDROXYBENZOYL)-N-ETHYLISOINDOLINE-1-CARBOXAMIDE |
3K99 | B:11-226; C:11-226; D:10-226; A:9-226 | HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH 4-(1,3-DIHYDRO-2H-ISOINDOL-2-YLCARBONYL)BENZENE-1,3-DIOL |